US 9676802
Hepatitis C virus inhibitors
granted A61KA61K31/13A61K31/4188
Quick answer
US patent 9676802 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K31/13, A61K31/4188, A61K31/4196, A61K31/422